SEDAR Interim Financial Statements

nDatalyze Corp. Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) NOTICE OF NO AUDITORS’ REVIEW OF INTERIM FINANCIAL STATEMENTS The accompanying unaudited interim condensed consolidated financial statements of nDatalyze Corp. have been prepared by and are the responsibility of the Company's management. The Company’s independent auditor has not performed a review of these financial statements. Calgary, Alberta January 23, 2026 The accompanying notes are an integral part of these financial statements - 3 - nDatalyze Corp. Interim Condensed Consolidated Statement of Financial Position expressed in Canadian dollars (unaudited) As at November 30, 2025 February 28, 2025 Assets (Audited) Current Cash $ 408,668 $ 522,958 Accounts receivable 9,236 15,546 Prepaid expenses and deposits - 99 417,904 538,603 Non-current Assets Furniture and Equipment, net of accumulated amortization 387 804 Intangibles (Note 5) 20,245 21,234 Total assets $ 438,536 $ 560,641 Liabilities Current Accounts payable and accruals $ 18,788 $ 24,478 Total liabilities 18,788 24,478 Shareholders' Equity Share capital (Note 7) $ 2,916,932 $ 2,916,932 Warrants (Note 8) - 58,109 Contributed surplus 1,726,980 1,668,871 Deficit (4,224,164) (4,107,749) Total shareholders’ equity 419,748 536,163 $ 438,536 $ 560,641 Going Concern (Note 2) Approved on behalf of the Board of Directors Jim Durward S. Price Director Director The accompanying notes are an integral part of these financial statements - 4 - nDatalyze Corp. Interim Condensed Consolidated Statement of Loss and Comprehensive Loss expressed in Canadian dollars For the three and nine months ended (unaudited) Revenues Three months ending November 30, 2025 Three months ending November 30, 2024 Nine months ending November 30, 2025 Nine months ending November 30, 2024 Sales $ - $ - $ - $ 1,714 Cost of Sales - 99 - 161 Gross margin $ - $ (99) $ - $ 1,553 Expenses Depreciation and amortization $ 464 $ 472 $ 1,406 $ 1,503 Advertising and promotion 4,537 4,743 18,093 17,392 Interest and bank charges 822 107 2,018 901 Contractors - 53,210 - 215,049 Legal, audit, and professional 12,825 21,734 63,484 96,616 Travel, meals and entertainment 988 6,321 3,125 9,978 Research and development 29,634 18,171 40,657 74,765 Research and development tax credit - - (10,569) - Investor relations 25,480 47,090 35,575 140,893 Office expenses 982 2,014 2,052 6,139 Accounting 4,000 5,000 10,000 10,000 Total expenses $ 79,732 $ 158,862 $ 165,841 $ 573,236 Other Income Gain on sale of subsidiary (Note 6) $ - $ 243,499 $ - $ 243,499 Other income 42,000 - 42,000 - Impairment of goodwill on sale of subsidiary (Note 6) - (56,000) - (56,000) Foreign exchange gain (loss) - 2,515 143 (1,009) Interest Income 1,909 5,162 7,283 18,693 Total other income $ 43,909 $ 195,176 $ 49,426 $ 205,183 Net operating loss and comprehensive loss $ (35,823) $ 36,215 $ (116,415) $ (366,500) Loss per share (basic and diluted) $ (0.00) $ (0.00) $ (0.00) $ (0.01) Weighted average shares outstanding (basic and diluted) 41,327,425 41,617,533 41,327,425 41,981,771 The accompanying notes are an integral part of these financial statements - 5 - nDatalyze Corp. Interim Condensed Consolidated Statement of Changes in Shareholders’ Equity expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) Share Capital ($) Warrants ($) Contributed Surplus ($) Deficit ($) Shareholders’ Equity ($ --- ) As at February 29, 2024 2,665,939 58,109 1,668,871 (3,553,273) 839,646 Share issuances 207,315 - - - 207,315 Finders fees shares on acquisition 56,000 - - - 56,000 Shares returned for cancellation on Mindbalanced sale (115,000) - - - (115,000) Finders fees shares returned for cancellation on Mindbalanced sale (11,500) - - - (11,500) Share issue costs (12,322) - - - (12,322) Net loss - - - (366,500) (366,500) As at November 30, 2024 2,790,432 58,109 1,668,871 (3,919,773) 597,639 As at February 28, 2025 2,916,932 58,109 1,668,871 (4,107,749) 536,163 Warrants expired unexercised - (58,109) 58,109 - - Net loss - - - (116,415) (116,415) As at November 30, 2025 2,916,932 - 1,726,980 (4,224,164) 419,748 The accompanying notes are an integral part of these financial statements - 6 - nDatalyze Corp. Interim Condensed Consolidated Statement of Cash Flows expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) Cash provided by (used in): November 30, 2025 November 30, 2024 Operating activities Net loss $ (116,415) $ (366,500) Adjustments for non-cash items: Gain on sale of Mindbalanced - (243,499) Impairment of goodwill - 56,000 Non-cash items on Mindbalanced sale - 117,000 Depreciation and amortization 1,406 1,503 Change in non-cash working capital (Note 12) 719 36,226 Cash flows used in operating activities $ (114,290) $ (399,270) Financing activities Issuance of common shares, net of costs (Note 7) - 194,993 - 194,993 Decrease in cash (114,290) (204,277) Cash, beginning of period 522,958 794,101 Cash, end of period $ 408,668 $ 589,824 nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 7 - 1. Incorporation and operations nDatalyze Corp. the "Company" was incorporated on January 24, 2018 by Certificate of Incorporation issued pursuant to the provisions of the Business Corporations Act (Alberta). On October 22, 2021 the Company changed its name to nDatalyze Corp. The Company generates technologically-based solutions related to applying machine learning to a proprietary records database to predict probable mental health conditions. The Company is publicly trading and listed on the Canadian Securities Exchange (CSE:NDAT) and the USOTCQB (NDATF). On July 13, 2020, the Company incorporated a wholly-owned subsidiary 2273670 Alberta Ltd. for manufacturing alcohol-based extractors (and has since discontinued). The head office and registered office of the Company is located at Suite 1150, 707 – 7th Ave. SW Calgary, Alberta T2P 3H6. On April 16, 2024 the Company acquired Mindbalanced Inc. (“MB”) of Florida, USA. MB operating in multiple US States, is revolutionizing mental healthcare through its integrative and individualized approach. Utilizing advanced AI and biometric data analysis, MB envisions delivery of highly-informed insights into mental health conditions, facilitating personalized treatment plans designed to enhance patient outcomes. On November 6, 2024 the Company sold MB. A shareholder of the Company returned 1,000,000 common shares to treasury for cancellation. 2. Basis of preparation Statement of compliance These financial statements for the nine months ended November 30, 2025 are unaudited and have been prepared in accordance with IAS 34 Interim Financial Reporting using accounting policies consistent with International Financial Reporting Standards (“IFRS”), as issued by the International Acco --- unting Standards Board (“IASB”) and interpretations issued by the International Financial Reporting Interpretations Committee (“IFRIC”) in effect for the period beginning March 1, 2024. These interim condensed financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ending February 28, 2025. These financial statements were authorized for issue in accordance with a resolution of the directors on January 23, 2026. Going Concern These financial statements have been prepared on a going concern basis, which assumes that the Company will continue to operate for the foreseeable future and will be able to realize its assets and discharge its liabilities in the normal course of business. The Company has cumulative deficit of $4,224,164 and used cash flow in operating activities for the nine months ended November 30, 2025 of $114,290. The Company has experienced declining revenues and its mental health application has not yet generated revenues. As a result of these risks, there exists a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. The financial statements do not reflect adjustments that would be necessary if the going concern basis was not appropriate. Consequently, adjustments would then be necessary to the carrying value of assets and liabilities, the reported revenues and expenses and their classifications. Such adjustments, if required, could be material. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 8 - Basis of measurement These financial statements are stated in Canadian dollars which is the Company’s functional currency and are prepared on a going concern basis, under the historical cost convention. Use of estimates and judgments The preparation of financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates. Areas where estimates are significant to the financial statements are disclosed in Note 4. Basis of consolidation These consolidated financial statements include the financial statements of nDatalyze Corp. and its wholly- owned subsidiaries, 2273670 Alberta Ltd., a company incorporated in Alberta on July 13, 2020, and MB subsequent to acquisition date of April 16, 2024 until the sale of MB on November 6, 2024. MB had no revenues from acquisition date to November 6, 2024. Control is achieved when the Company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities. The results of the subsidiary incorporated during the year are included in the consolidated statements of loss and comprehensive loss from the date of incorporation or acquisition. All intercompany transactions, balances, income and expenses are eliminated through the consolidation process. The accounts of the subsidiary are prepared for the same reporting period as the parent company, using consistent accounting policies. 3. Significant accounting policies Accounting policies as descr --- ibed in the audited financial statements and the notes thereto for the year ended February 28, 2025. Functional and presentation currency- Items included in the financial statements of the Company’s foreign subsidiary MB were measured using USD (the "functional currency") and converted to CAD for presentation in the financial statements. 4. Significant accounting estimates and judgements The preparation of the financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and contingent liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Estimates and judgments are continuously evaluated and are based on management’s experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Actual outcomes can differ from these estimates. Estimates The key sources of estimation uncertainty that have a significant risk of causing material adjustment to the amounts recognized in the financial statements are: Fair value of financial instruments The estimated fair value of financial assets and liabilities, by their very nature, are subject to measurement uncertainty. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 9 - Taxes Provisions for taxes are made using the best estimate of the amount expected to be paid based on a qualitative assessment of all relevant factors. The Company reviews the adequacy of these provisions at the end of the reporting period. However, it is possible that at some future date an additional liability could result from audits by taxing authorities. Where the final outcome of these tax-related matters is different from the amounts that were initially recorded, such differences will affect the tax provisions in the period in which such determination is made. Share based payment transactions The Company measures the cost of equity-settled share-based transactions with employees by reference to the fair value of the equity instruments at the date at which they are granted. Estimating fair value for share-based payment transactions requires determining the most appropriate valuation model, which is dependent on the terms and conditions of the grant. This estimate also requires determining the most appropriate inputs to the valuation model including the expected life of the share option, volatility, forfeiture rate, risk-free rate and dividend yield and making assumptions about them. Judgements The key areas of judgment which have been made in the process of applying the Company’s accounting policies: Impairment of non-financial assets The determination of whether indicators of impairment exist and the aggregation of assets into cash-generating units (“CGU’s”) based on their ability to generate independent cash flows are subject to management’s judgment. The recoverable amounts used for impairment calculations require estimates of future cash flows related to the assets or CGU’s and estimates of discount rates applied to these cash flows. Taxes The Company recognizes deferred tax assets to the extent that it is probable that future taxable profits will be available to utilize the Company’s deductible temporary differences which are based on management’s judgement on the degree of futu --- re taxable profits. To the extent that future taxable profits differ significantly from the estimates impacts the amount of the deferred tax assets management judges is probable. Financial instruments The Company is required to classify its various financial instruments into certain categories for the financial instruments’ initial and subsequent measurement. This classification is based on management’s judgement as to the purpose of the financial instrument and to which category is most applicable. The Company has made a judgment regarding vendor performance. 5. Intangibles assets November 30, 2025 February 28, 2025 Intangible assets, cost 26,282 26,282 Accumulated amortization (6,037) (5,048) Intangible assets, net of accumulated amortization $ 20,245 $ 21,234 On February 22, 2018, the Company acquired intangible assets including Canadian and US patents, URL website address, and all intellectual rights relating to the essential oil extraction technology. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 10 - 6. Acquisition of Mindbalanced Inc. (“MB”) and Subsequent Sale of MB On April 16, 2024 the Company acquired MB of Florida, USA. Transaction details as set out below: Consideration paid August 31, 2024 Estimated fair value of shares to be issued to acquire MB in the event sales targets are met - (up to 15,000,000 and 300,000 finders fees shares) $ - Fair value of 400,000 shares issued on closing – finders fees 56,000 Estimated total acquisition cost of MB $ 56,000 At date of acquisition, MB had no material assets or liabilities. Finders fees of 400,000 shares were issued on closing with an estimated fair value of $56,000 – the market price of Company shares. As the transaction was performance-driven, the number of Company shares issued to vendors was potentially between zero and 15,000,000 depending on MB performance: a) upon achieving CAD$1,000,000 of gross revenue from MB operations and within one year after the closing, MB nominees were to receive either 4,000,000 shares or 6,000,000 shares if met within the first six months; b) upon achieving CAD$2,500,000 of gross revenues from MB operations within two years after closing, MB nominees were to receive either 6,000,000 shares or 9,000,000 shares if met within the first twelve months. c) 300,000 finders fee shares contingent upon MB’s achieving CAD$1,000,000 of gross revenue from MB operations within one year after the closing. On November 6, 2024 the Company closed its sale of MB. A former shareholder of the Company purchased MB and returned 1,000,000 nDatalyze common shares to treasury for cancellation. As well, the Finder of the acquisition returned 100,000 common shares to the Company treasury for cancellation. At the date of the loss of control of the subsidiary, MB had net liabilities of $116,999 which has been recognized as a gain on deconsolidation. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 11 - 7. Share capital Authorized: Unlimited number of voting Common Shares without par value Unlimited number of non-voting Preferred shares issuable in series without par value Issued: Common Shares Number of Shares $ As at February 29, 2024 41,027,425 2,665,939 Common shares issued (i) 1,000,000 207,315 Common shares returned to treasury for --- cancellation on sale of MB (ii) (1,000,000) - Finders fees shares issued on acquisition of MB (Note 6) 400,000 56,000 Refund Finders fees shares returned to treasury for cancellation on sale of MB (100,000) - Cash Finder fees (12,322) As at February 28 2025 and November 30, 2025 41,327,425 2,916,932 i) On May 7, 2024 the Company closed an arm’s-length private placement of 1,000,000 common shares at US$0.15 per Share (US$150,000), CAD$207,315 CAD$0.21 per Share. A 6% finders fee of US$9,000 was paid. ii) On November 6, 2024 as part of the sale agreement of MB, the Company received from the MB purchaser, 1,000,000 nDatalyze common shares and 100,000 from the Finder for return to treasury and cancellation. 8. Warrants Warrants Number of warrants outstanding Value Average Exercise price Weighted average life (in years) As at February 28, 2025 1,197,500 $ 58,109 $0.25 1.19 Warrants expired unexercised (1,197,500) (58,109) $0.25 - As at November 30, 2025 - $ - - - 9. Capital disclosures The Company’s capital consists of share capital. The Company sets the amount of capital in relation to risk and manages the capital structure and makes adjustments to it in light of changes to economic conditions and the risk characteristics of the underlying assets. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 12 - The Company’s objectives when managing capital are: i. to maintain a flexible capital structure, which optimizes the cost of capital at acceptable risk; and, ii. to maintain investor, creditor and market confidence in order to sustain the future development of the business. The Company is not subject to any externally or internally imposed capital requirements at period-end. 10. Financial instruments The Company, as part of its operations, carries financial instruments consisting of cash, accounts receivable, and accounts payable and accruals. It is management's opinion that the Company is not exposed to significant credit, interest, or currency risks arising from these financial instruments except as otherwise disclosed. Fair value Fair value represents the price at which a financial instrument could be exchanged in an orderly market, in an arm's length transaction between knowledgeable and willing parties who are under no compulsion to act. The Company classifies the fair value of the financial instruments according to the following hierarchy based on the amount of observable inputs used to value the instrument. Level 1: Fair value measurements are those derived from quoted prices (unadjusted) in the active market for identical assets or liabilities. Level 2: Fair value measurements are those derived from inputs other than quoted prices that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (derived from prices). Level 3: Fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data. The fair value of cash is determined on level 1 inputs. The carrying amount of cash, accounts receivable, and account payable and accruals approximates its fair value due to the short-term maturities of these items. Credit Risk Credit risk is the risk of loss associated with the counterparty's inability to fulfill its payment obligations. The Company believes it has no significant credit risk. Liquidity Risk T --- he Company's approach to managing liquidity risk is to ensure that it will have sufficient liquidity to meet liabilities when due. Market Risk Market risk is the risk of loss that may arise from changes in market factors such as interest rates, foreign exchange rates, and commodity and equity prices. i. Interest rate risk The Company has cash balances and no interest-bearing debt. ii. Foreign currency risk As at November 30, 2025, the Company had $3,437 in cash denominated in US Dollars foreign currency. nDatalyze Corp. Notes to the Interim Condensed Consolidated Financial Statements expressed in Canadian dollars For the nine months ended November 30, 2025 (unaudited) - 13 - iii. Commodity risk The Company is not exposed to commodity price risk. 11. Stock Option Plan The Company has a stock option plan for its officers, directors, employees and consultants. The maximum number of common shares issuable under the Plan cannot exceed 10% of the Company's issued and outstanding common shares. Stock Options Number of options outstanding and exercisable Weighted average exercise price Weighted average life (in years) As at February 28, 2025 3,650,000 $0.08 0.60 Stock option expired and unexercised (3,350,000) $0.08 - As at November 30, 2025 300,000 $0.16 0.62 12. Changes in non-cash working capital Nine months ended November 30, 2025 $ Nine months ended November 30, 2024 Accounts receivable $ 6,310 $ 48,387 Prepaid expenses 99 99 Accounts payable and accruals (5,690) (12,260) Changes in non-cash working capital $ 719 $ 36,226 13. Related Party Transactions Key management personnel The Company has determined that the key management personnel of the Company consists of its officers and directors. The following table provides information on compensation expense related to officers and directors. Nine Months ended November 30, 2025 Year ended February 28, 2025 Legal, audit and professional 28,510 $ 39,190 Contractor 15,110 42,030 Total 43,620 $ 81,220